Current Concepts in Hematopathology 2022 (CME VIDEOS)

In this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. Current Concepts in Hematopathology delivers continuing medical education insights, including:

common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations
approaches to cases that do not conform to WHO diagnostic categories
use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis

Learning Objectives

Upon completion of this activity, participants will be able to:

Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies
Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms
Diagnose challenging cases that do not readily conform to well-established entities
Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy

Target Audience

This course is targeted to specialty physicians who practice in pathology.

TOPICS / SPEAKERS

Nodal Small B-Cell Lymphomas – Elizabeth A. Morgan, MD

Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma – Valentina Nardi, MD

Question & Answer – Robert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD

Immunodeficiency and Viral-Associated Lymphoproliferations – Judith A. Ferry, MD

Updates in Cutaneous Lymphomas – Sam Sadigh, MD

Question & Answer – Elizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD

WHO Update – Follicular Lymphoma and Related Entities – Abner Louissaint Jr., MD, PhD

Diffuse Large B-Cell Lymphoma Subtypes – Scott B. Lovitch, MD, PhD

Question & Answer – Marian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD

Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – Aliyah R. Sohani, MD

Reactive Lymphadenopathies and Castleman Disease – Yasodha Natkunam, MD, PhD

Question & Answer – Robert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD

Approach to Peripheral Smear Review – Elizabeth Courville, MD

Myelodysplastic Syndrome and Its Differential Diagnosis – Robert P. Hasserjian, MD

Question & Answer – Elizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD

Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage – Olga K. Weinberg, MD

Acute Lymphoblastic Leukemia – Marian H. Harris, MD, PhD

Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD

Eosinophilia and Mastocytosis – Olga Pozdnyakova, MD, PhD

Myelodysplastic/Myeloproliferative Neoplasms – Robert P. Hasserjian, MD

Question & Answer – Marian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD

Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia – Sa A. Wang, MD

Practical Interpretation of Molecular Testing in Myeloid Neoplasms – Annette S. Kim, MD, PhD

Question & Answer – Elizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD

Challenges in the Diagnosis of Hodgkin Lymphomas – Marian H. Harris, MD, PhD

Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas – Scott J. Rodig, MD, PhD

Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD

Indolent T-Cell Disorders – Kathleen H. Burns, MD, PhD

Nodal T-Cell Lymphomas – Roberto Chiarle, MD

Question & Answer – Marian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD

Histiocytic and Dendritic Cell Neoplasms – Elizabeth A. Morgan, MD

IgG4-Related Disease and Lymphadenopathy – Jacob R. Bledsoe, MD

Blastic Plasmacytoid Dendritic Cell Neoplasm – Gabriel K. Griffin, MD

Question & Answer – Marian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD

Inherited Predisposition to Myeloid (and Hematological) Malignancies – Mark D. Fleming, MD, DPhil

Spleen Pathology – Lawrence R. Zukerberg, MD

Question & Answer – Elizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD

Date of Original Release: June 30, 2022

Termination Date: June 30, 2025

Current Concepts in Hematopathology 2022 (CME VIDEOS)

common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations
approaches to cases that do not conform to WHO diagnostic categories
use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis

Learning Objectives

Upon completion of this activity, participants will be able to:

Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies
Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms
Diagnose challenging cases that do not readily conform to well-established entities
Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy